Cost effectiveness of blood transfusion

Vox Sanguinis

Volumn 70, Issue SUPPL. 3, 1996, Pages 86-88

  Koistinen, Jukka ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Blood transfusion; Cost effectiveness

Indexed keywords

BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; LABORATORY TEST; PRIORITY JOURNAL;

EID: 0029885392     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1996.tb01377.x     Document Type: Conference Paper

References (7)

1. Brand A: Cost effectiveness of leukocyte depletion. In Leukocyte-depleted blood products (ed. T.A.Lane, G.Myllyl*), pp.134-143, S. Karger AG, Basel, 1994.
2. Busch MP, Alter HJ: Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? Editorial. Transfusion 35:536-539, 1995.
3. Forbes JM, Anderson MD, Bleecker GC, Rossi EC, Moss GS: Blood transfusion costs: a multicenter study. Transfusion 31: 318-323, 1991.
4. Jensen LS, Grunnet N, Hanberg-Sîrensen F, Jîrgensen J: Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion 35: 719-722, 1995.
5. Morgenthaler JJ: Importance of plasma source limitations and cost of current virus attenuation methods. Sangre 39:186-187, suppl.1, 1994.
6. Sirchia G, Giovanetti AM, McClelland B, Fracchia GN(eds): Safe and Good Use of Blood in Surgery (SANGUIS). European Commission, DG Xll, 1994.
7. Trenchard PM, Dixon R: Blood product costing: relationship to price and clinical efficacy. Transf.Med. 5:231-240, 1995.